Galectin (GALT) Posts Q2 Loss of 17c/Share

Galectin (NASDAQ: GALT) reported Q2 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Galectin (GALT) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Global Net Lease completes Modiv Industrial acquisition for $535M
• Nvidia and Broadcom AI financing deals raise long-term concerns, Wolfe Research comments